Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 50,000 shares at $47.00 ($2.3M) on 2020-05-12, disclosed to the SEC on 2020-05-13.
Open-market sale of $2.3M ATRC by President, CEO, & Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $46.00 | 25,000 | $1.1M | 49.5% |
| 2 | $47.00 | 25,000 | $1.2M | 50.5% |
| Total | $46.50 avg | 50,000 | $2.3M | 100% |
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |